What happens when one of the most exciting stem cell biotechs ViaCyte teams up with a firm like CRISPR Therapeutics to use a combination of gene editing and cell therapy? Hopefully a synergistic partnership emerges that in this case can […]

The post ViaCyte & CRISPR Therapeutics team up to battle diabetes appeared first on The Niche.